Yadin Rozov's most recent trade in Dave Inc - Ordinary Shares - Class A was a trade of 4,726 Class A Common Stock done . Disclosure was reported to the exchange on June 3, 2024.
Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
---|---|---|---|---|---|---|---|---|---|---|
Dave Inc - Ordinary Shares... | Yadin Rozov | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jun 2024 | 4,726 | 101,178 | - | 0 | Class A Common Stock | |
Dave Inc - Ordinary Shares... | Yadin Rozov | Director | Purchase of securities on an exchange or from another person at price $ 37.31 per share. | 07 Mar 2024 | 800 | 96,452 | - | 37.3 | 29,848 | Class A Common Stock |
Oramed Pharmaceuticals, Inc | Yadin Rozov | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Jan 2024 | 30,000 | 146,500 (0%) | 0% | - | Common Stock | |
Oramed Pharmaceuticals, Inc | Yadin Rozov | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Jan 2024 | 8,820 | 155,320 (0%) | 0% | - | Common Stock | |
Dave Inc - Ordinary Shares... | Rozov Yadin | Director | Purchase of securities on an exchange or from another person at price $ 6.40 per share. | 04 Dec 2023 | 12,941 | 95,652 | - | 6.4 | 82,760 | Class A Common Stock |
Dave Inc - Ordinary Shares... | Yadin Rozov | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Jul 2023 | 30,239 | 82,711 | - | 0 | Class A Common Stock | |
Midwest Hldg Inc | Yadin Rozov | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Jun 2023 | 1,164 | 23,825 | - | 0 | Common Stock | |
Oramed Pharmaceuticals, Inc | Yadin Rozov | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Apr 2023 | 30,000 | 116,500 (0%) | 0% | - | Common Stock | |
Oramed Pharmaceuticals, Inc | Yadin Rozov | Director | Purchase of securities on an exchange or from another person at price $ 2.05 per share. | 13 Mar 2023 | 50,000 | 86,500 (0%) | 0% | 2.0 | 102,450 | Common Stock |
Oramed Pharmaceuticals, Inc | Yadin Rozov | Director | Purchase of securities on an exchange or from another person at price $ 1.96 per share. | 13 Mar 2023 | 20,000 | 36,500 (0%) | 0% | 2.0 | 39,120 | Common Stock |
Oramed Pharmaceuticals, Inc | Yadin Rozov | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Jul 2022 | 12,000 | 16,500 (0%) | 0% | - | Common Stock | |
Midwest Hldg Inc | Yadin Rozov | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Jun 2022 | 2,674 | 22,661 | - | 0 | Voting Common Stock | |
Oramed Pharmaceuticals, Inc | Yadin Rozov | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 May 2022 | 7,500 | 7,500 | - | - | Stock Option (right to buy) | |
Oramed Pharmaceuticals, Inc | Yadin Rozov | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 May 2022 | 4,500 | 4,500 (0%) | 0% | - | Common Stock |